参考文献/References:
［1］ 陈自谦， 杨 利， 杨熙章， 等． 肝癌介入治疗现状与进展［J］． 介入放射学杂志， 2008， 17： 223- 227．
［2］ 赵 宏， 蔡建强． 原发性肝癌非手术治疗的现状与展望［J］． 中华肝胆外科杂志， 2011， 17： 527- 530．
［3］ Kooby DA, Egnatashvili V, Srinivasan S, et al. Comparison of yttrium- 90 radioembolization and transcatheter arterial chemoembo lization for the treatment of unresectable hepatocellular carcinoma［J］. J Vasc Interv Radiol, 2010, 21: 224- 230.
［4］ Buijs M, Reyes DK, Pawlik TM, et al. Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma［J］. Cancer, 2013, 119: 1042- 1049.
［5］ Meyer T, Kirkwood A, Roughton M, et al. A randomised phase Ⅱ/Ⅲ trial of 3- weekly cisplatin- based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma［J］. Br J Cancer, 2013, 108: 1252- 1259.
［6］ Carr BI, Kondragunta V, Buch SC, et al. Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two- cohort study ［J］. Cancer, 2010, 116: 1305- 1314.
［7］ Suk OJ, Jong CH, Gil CB, et al. Transarterial chemoembolization with drug- eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone- beam computed tomography imaging for predicting short- term tumor response ［J］. J Vasc Interv Radiol, 2013, 24: 483- 489.
［8］ Kan RW, Tsang SH, Poon RT, et al. Update on yttrium- 90- based radio- embolization for treatment of hepatocellular carcinoma［J］. ANZ J Surg, 2012, 82: 505- 509.
［9］ Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma［J］. Semin Intervent Radiol, 2013, 30: 3- 11.
［10］ Miyayama S, Yamashiro M， Hashimoto M, et al. Identification of small hepatocellular carcinoma and tumor- feeding branches with cone- beam CT guidance technology during transcatheter arterial chemoembolization ［J］. J Vasc Interv Radiol, 2013, 24: 501- 508.
［11］ Angle JF. Cone- beam CT: vascular applications［J］. Tech Vasc Interv Radiol, 2013, 16: 144- 149.
［12］ Yamakado K, Miyayama S, Hirota S, et al. Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?［J］. Jpn J Radiol, 2012, 30: 560- 566.
［13］ Miyayama S, Yamashiro M, Hattori Y, et al. Efficacy of cone- beam computed tomography during transcatheter arterial chemoembolization for hepatocellular carcinoma［J］. Jpn J Radiol， 2011, 29: 371- 377.
［14］ Iwazawa J, Ohue S, Hashimoto N, et al. Comparison of the Number of Image Acquisitions and Procedural Time Required for Transarterial Chemoembolization of Hepatocellular Carcinoma with and without Tumor- Feeder Detection Software［J］. Radiol Res Pract, 2013: 580839.
［15］ Liang X, Lambrichts I, Sun Y, et al. A comparative evaluation of Cone Beam Computed Tomography （CBCT） and Multi- Slice CT （MSCT）. Part II: On 3D model accuracy［J］. Eur J Radiol, 2010, 75: 270- 274.
［16］ Kim MU, Kim HC, Chung JW, et al. Hepatocellular carcinoma： prediction of blood supply from an intercostal artery with multidetector row computed tomography［J］. J Vasc Interv Radiol, 2011, 22: 1403- 1408.
［17］ Miyayama S, Yamashiro M, Okuda M, et al. Usefulness of cone- beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiography［J］. Cardiovasc Intervent Radiol, 2009, 32: 255- 264.
［18］ 肖运平， 肖恩华． C臂CT在介入诊疗中的应用［J］． 介入放射学杂志， 2011， 20： 249- 252．
［19］ 孙勤学， 董海波， 张贵军， 等． C臂CT在肝癌介入治疗中的应用［J］． 介入放射学杂志， 2010， 19： 988- 991．
［20］ Deschamps F, Solomon SB, Thronton RH, et al. Computed analysis of Three- Dimensional Cone- Beam computed tomography angiography for determination of Tumor- Feeding vessels during chemoembolization of liver tumor: a pilot study［J］. Cardiovasc Intervent Radiol, 2010, 33: 1235- 1242.
［21］ Iwazawa J, Ohue S, Hashimoto N, et al. Accuracy of software- assisted detection of tumour feeders in transcatheter hepatic chemoembolization using three target definition protocols ［J］. Clin Radiol, 2014, 69: 145- 150.
［22］ Iwazawa J, Ohue S, Hashimoto N, et al. Clinical utility and limitations of tumor- feeder detection software for liver cancer embolization［J］. Eur J Radiol, 2013, 82: 1665- 1671.
［23］ Wang X, Shah RP, Maybody M, et al. Cystic artery localization with a three- dimensional angiography vessel tracking system compared with conventional two- dimensional angiography［J］. J Vasc Interv Radiol, 2011, 22: 1414- 1419.